Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04112823 · ClinicalTrials.gov registry record · Phase 4
Dexamethasone for Migraine - Dose Comparison
A Phase 4 study, sponsored by Montefiore Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 209
- Enrollment target
NCT04112823 is a Phase 4 study that has completed, run by Montefiore Medical Center. The registered enrollment target is 209 participants.
The verdict
NCT04112823, a Phase 4 study, has completed, sponsored by Montefiore Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 209 participants
- Enrollment target
Study Summary
Dexamethasone is an evidence-based treatment of acute migraine. This is a randomized comparison of two different doses of dexamethasone for acute migraine. All patients will also be treated with metoclopramide.
Interventions
- DRUG Dexamethasone 4mg
- DRUG Dexamethasone 16mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 209 participants |
| Start Date | 2019-12-22 |
| Est. Completion | 2022-12-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04112823
The ClinicalTrials.gov registry entry for NCT04112823 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 209 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Dexamethasone 4mg is the first listed.
NCT04112823 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04112823 about?
NCT04112823 is a clinical study titled "Dexamethasone for Migraine - Dose Comparison". Dexamethasone is an evidence-based treatment of acute migraine. This is a randomized comparison of two different doses of dexamethasone for acute migraine. All patients will also be treated with metoclopramide.
What is the current status of trial NCT04112823?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 209 participants. The study started on 2019-12-22. Estimated completion is 2022-12-31.
What interventions are being tested in trial NCT04112823?
The interventions under investigation include: Dexamethasone 4mg (DRUG), Dexamethasone 16mg (DRUG).
Who is sponsoring clinical trial NCT04112823?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.